Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults… https://t.co/swFNa4Nbv6
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥65 years.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2019 – Oct 2024Where it's discussed
-
News255 articles
-
X / Twitter12 posts
-
Facebook8 posts
-
Blogs6 articles
-
YouTube1 videos
AI synopsis
What people are saying
Discussions reflect a balanced interest in the article's findings, with examples like a tweet questioning the lack of recent studies and others highlighting the economic costs and disparities among racial groups. The tone varies from concern to curiosity, with phrases like 'long time to go without new research' and 'costly disease,' which underscores the importance and relevance of this issue.
Most discussions acknowledge the importance of the study and its projections, indicating general agreement with the emphasis on disparities and future impact.
Participants show moderate interest, evidenced by questions about the need for updated research and comments on the disease's cost and societal impact.
Several posts reference specific aspects of the article, such as disparities among racial groups and policy implications, demonstrating moderate depth in engagement.
The topic is perceived as significant, with mentions of the disease's economic cost, healthcare burden, and social stigma, indicating a recognition of high impact.
Abstract in brief
- The study estimates that Alzheimer’s disease and related dementias (ADRD) affected about 50 million adults aged 65 and older in 2014, which is about 16% of that age group in the U.S., and this number is expected to double to 139 million by 2060.
- There are notable disparities in ADRD prevalence among different racial and ethnic groups, highlighting the importance of considering these factors in public health planning.
- These projections can help guide future policies, healthcare planning, and support systems for individuals with ADRD and their caregivers as the disease burden increases.
Top posts
Most liked on X and Bluesky4) Note that Alzheimer disease is an incredibly costly disease – and the 6th leading cause of death in the U.S. (5th ≥65y) – and its prevalence has been projected to double to triple until 2050-2060 (https://t.co/lnGB8aQnzp, https://t.co/r3twMoYg2i)
RT @Scott_M_Reid: Projected number of adults age 65+ with #alzheimers or related #dementia 2015-2060 by all groups, sex, age, and race and…
@Dawnsearlylig10 In addition to COVID-related neurological issues... https://t.co/CPUMXHwy6E https://t.co/UfHdIhZBgB
RT @Scott_M_Reid: Projected number of adults age 65+ with #alzheimers or related #dementia 2015-2060 by all groups, sex, age, and race and…
Fighting stigma — Association of Endocrine Therapy and Dementia in Women with Breast Cancer: This study was institutional review board approved by MD Anderson ... Racial and ethnic estimates of Alzheimer's disease and related dementias in ... https://t.co/nrsZtHdakf
All mentions
Understanding Alzheimer's Disease and Provider Responsibilities
This video discusses Alzheimer's disease and related conditions, highlighting provider responsibilities when delivering services to affected individuals. It emphasizes the growing prevalence and disparities across…
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years https://t.co/78moIzR6P7
@NewsHour Are there any new studies on this since the actual September 2018 study referenced in most of the CDC blog postings? 5 years is a LONG time to go without a new and meaningful study on this critical topic. https://t.co/4Xn7p7aJ0C
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults… https://t.co/swFNa4Nbv6
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years https://t.co/hoCkQWRZwY
@Dawnsearlylig10 In addition to COVID-related neurological issues... https://t.co/CPUMXHwy6E https://t.co/UfHdIhZBgB
4) Note that Alzheimer disease is an incredibly costly disease – and the 6th leading cause of death in the U.S. (5th ≥65y) – and its prevalence has been projected to double to triple until 2050-2060 (https://t.co/lnGB8aQnzp, https://t.co/r3twMoYg2i)
RT @stigmabase: Fighting stigma — Association of Endocrine Therapy and Dementia in Women with Breast Cancer: This study was institutional…
Fighting stigma — Association of Endocrine Therapy and Dementia in Women with Breast Cancer: This study was institutional review board approved by MD Anderson ... Racial and ethnic estimates of Alzheimer's disease and related dementias in ... https://t.co/nrsZtHdakf
RT @Scott_M_Reid: Projected number of adults age 65+ with #alzheimers or related #dementia 2015-2060 by all groups, sex, age, and race and…
RT @Scott_M_Reid: Projected number of adults age 65+ with #alzheimers or related #dementia 2015-2060 by all groups, sex, age, and race and…
RT @Scott_M_Reid: Projected number of adults age 65+ with #alzheimers or related #dementia 2015-2060 by all groups, sex, age, and race and…
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥65 years. - PubMed - NCBI https://t.co/NH3C0w3t8q